Celltrion
068270.KS
#679
Rank
C$50.94 B
Marketcap
C$223.43
Share price
-0.47%
Change (1 day)
33.36%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): C$4.04

According to Celltrion 's latest financial reports the company's current EPS (TTM) is C$4.59. In 2022 the company made an earnings per share (EPS) of C$4.10 a decrease over its 2021 EPS that were of C$4.88.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$4.04-1.45%
2022C$4.10-15.84%
2021C$4.8812.77%
2020C$4.3270.79%
2019C$2.5315.63%
2018C$2.19-33.13%
2017C$3.27141.17%
2016C$1.368.28%
2015C$1.2511.28%
2014C$1.1316.37%
2013C$0.97-67.42%
2012C$2.9784.22%
2011C$1.6162.13%
2010C$1.0080.61%
2009C$0.55-559.63%
2008C-$0.12-123.16%
2007C$0.52